The Adiponectin Receptor Agonist, ALY688: A Promising Therapeutic for Fibrosis in the Dystrophic MuscleNicolas Dubuisson(Cliniques Universitaires Saint-Luc), Michel Abou‐Samra(UCLouvain)CellsAugust 19, 202310.3390/cells12162101Cited by 13SaveCiteExport RISWatch citationsRelated PapersInvolvement of adiponectin in the pathogenesis of dystrophinopathy|Skeletal Muscle|2015|55Striking Cardioprotective Effects of an Adiponectin Receptor Agonist in an Aged Mouse Model of Duchenne Muscular Dystrophy|Antioxidants|2024|3